Skip to main content

Table 1 Main baseline clinical and biochemical characteristics of the study population

From: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

  Baseline values Difference between arms at baseline (P-value)
Age (years) 57 (48, 63) 0.01
Weight (kg) 65 (62, 78) 0.43
BMI (kg/m2) 24 (21, 27) 0.89
WC (cm) 88 (84, 94) 0.91
BIA (%) 31 (27, 40) 0.99
VFR (%) 11 (8, 12) 0.91
SBP (mmHg) 120 (120, 130) 0.54
DBP (mmHg) 80 (80, 80) 0.88
HR (bpm) 64 (60, 68) 0.24
TC (mg/mL) 271 (247, 288) 0.51
LDL-C (mg/mL) 180 (170, 196) 0.29
HDL-C (mg/mL) 60 (43, 77) 0.51
Non-HDL-C (mg/mL) 210 (193, 228) 0.24
TG (mg/mL) 115 (94, 150) 0.79
apoAI (mg/dL) 118 (95, 133) 0.28
apoB (mg/dL) 146 (134, 155) 0.07
oxLDL (U/L) 76.6 (69.7, 86.7) 0.08
Lp(a) (mg/dL) 6 (4, 12) 0.32
PCSK9 (ng/dL) 341 (285, 403) 0.81
FPG (mg/dL) 95 (89, 98) 0.97
Insulin (mUI/L) 3.38 (2.46, 4.92) 0.64
HOMA-IR 0.75 (0.57, 1.15) 0.72
FGF19 (pg/mL) 227 (173, 337) 0.87
FGF21 (pg/mL) 179 (119, 229) 0.37
  1. Statistically significant P-values are indicated in bold
  2. BMI body mass index, WC waist circumference, BIA bioelectrical impedance analysis, VFR visceral fat rating, SBP Systolic blood pressure, DBP diastolic blood pressure, HR heart rate, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, apoA-I apolipoprotein A-I, apoB apolipoprotein B, oxLDL oxidize LDL, Lp(a) lipoprotein (a), PCSK9 proprotein convertase subtilisin/kexin type 9, FPG fasting plasma glucose, sICAM-1 soluble intercellular adhesion molecular 1, HOMA-IR Homeostatic Model Assessment of Insulin Resistance, FGF fibroblast growth factor